e-learning
resources
Stockholm 2002
Monday 16.09.2002
Genes and proteins in lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Angiotensin II and hypoxia synergistically induce proliferation in pulmonary artery fibroblasts by a PI-3K and PKC-signaling pathway through HIF-1 a and upregulation of angiotensin II-receptors type I
S. Krick, J. Hänze, J. Appel, A. H. Ghofrani, R. Schermuly, F. Grimminger, W. Seeger, F. Rose (Giessen, Germany)
Source:
Annual Congress 2002 - Genes and proteins in lung injury
Session:
Genes and proteins in lung injury
Session type:
Oral Presentation
Number:
2352
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Krick, J. Hänze, J. Appel, A. H. Ghofrani, R. Schermuly, F. Grimminger, W. Seeger, F. Rose (Giessen, Germany). Angiotensin II and hypoxia synergistically induce proliferation in pulmonary artery fibroblasts by a PI-3K and PKC-signaling pathway through HIF-1 a and upregulation of angiotensin II-receptors type I. Eur Respir J 2002; 20: Suppl. 38, 2352
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Autocrine secretion of bradykinin prevents alveolar type II cells from mechanical stretch-induced apoptosis by activation – role of PI3K and Akt
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008
Sildenafil modulates PDGF and Angiotensin II induced migration and proliferation in human pulmonary artery smooth muscle cells (PA-SMC)
Source: Eur Respir J 2002; 20: Suppl. 38, 227s
Year: 2002
Cross-talk between TGFbeta and angiotensin II signalling in lung fibroblast-induced collagen matrix contraction
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Inhibition of bradykinin breakdown by ACE inhibitors reduces mechanical stretch-induced apoptosis of alveolar type II cells
Source: Eur Respir J 2005; 26: Suppl. 49, 345s
Year: 2005
The growth factors HGF and KGF prevent mechanical stretch-induced apoptosis of alveolar Type II cells by restoration of mechanical stretch-induced decreased phosphatidylinositol 3-OH kinase (PI3K) activity
Source: Eur Respir J 2006; 28: Suppl. 50, 568s
Year: 2006
6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
Angiotensin II activates the hypoxia-responsive-element (HRE) in human alveolar epithelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 79s
Year: 2001
Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation
Source: Eur Respir J 2005; 26: Suppl. 49, 82s
Year: 2005
Pharmacological activation of Nur77 enhances BMP signalling and inhibits vascular remodelling in pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
mTORC1 hyperactivation in lymphangioleiomyomatosis leads to
ACE2
upregulation in type II pneumocytes: implications for COVID-19
Source: Eur Respir J, 57 (2) 2002737; 10.1183/13993003.02737-2020
Year: 2021
Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway
Source: Eur Respir J 2008; 31: 523-531
Year: 2008
Endothelin-1 downregulates BMP signaling in pulmonary artery smooth muscle cells
Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments
Year: 2012
Differential role of EPAC and PKA in the transduction of cAMP-mediated inhibition of human lung fibroblast proliferation and collagen synthesis
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Endothelin-1 activates pro-inflammatory signalling pathway via destinct p38MAPK isoforms resulting in downregulation of nuclear p27
kip1
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
VIP is an endogenous inhibitor of calcineurin-NFAT signalling
Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Year: 2009
Influence of protein kinase C on stretch-induced apoptosis in rat alveolar type II cells
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
New drugs for pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 233-246
Year: 2012
Glucocorticoids promote TGF-β signalling in lung fibroblasts by upregulating ligand and receptor expression, and uncoupling negative-feedback inhibition
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Endothelin-1 inhibits TASK-1 in human pulmonary artery smooth muscle cells via phospholipase C-diacylglycerol-protein kinase C-pathway
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept